MicroRNAs Activate Natural Killer Cells Through Toll-like Receptor Signaling.
Shun He,Jianhong Chu,Lai-Chu Wu,Hsiaoyin Mao,Yong Peng,Christopher A. Alvarez-Breckenridge,Tiffany Hughes,Min Wei,Jianying Zhang,Shunzong Yuan,Sumeet Sandhu,Sumithira Vasu,Don M. Benson,Craig C. Hofmeister,Xiaoming He,Kalpana Ghoshal,Steven M. Devine,Michael A. Caligiuri,Jianhua Yu
DOI: https://doi.org/10.1182/blood-2012-07-441360
IF: 20.3
2013-01-01
Blood
Abstract:MicroRNAs (miRNAs) bind to complementary sequences of target mRNAs, resulting in translational repression or target degradation and thus gene silencing. miRNAs are abundant in circulating blood, yet it is not known whether, as a class of regulatory molecules, they interact with human natural killer (NK) cells. Here we found that the treatment of human NK cells with several mature miRNAs in the presence of a low concentration of interleukin-12 induced CD69 expression, interferon-γ production, and degranulation marker CD107a expression. In vivo, infusion of several miRNAs alone in murine peripheral blood also resulted in comparable NK-cell activation, but not T-cell activation. Furthermore, miRNA administration significantly protected mice from tumor development in an NK cell-dependent manner. Mechanistically, we found that miRNA stimulation led to downstream activation of nuclear factor κB (NF-κB), an effect that was blunted by a block in Toll-like receptor 1(TLR1) signaling and attenuated in lymphoma patients. Knockdown of TLR1 resulted in less activation by miRNAs. Collectively, we show that miRNAs have a capacity to selectively activate innate immune effector cells that is, at least in part, via the TLR1-NF-κB signaling pathway. This may be important in the normal host defense against infection and/or malignant transformation.